Ambrilia Biopharma

Ambrilia Biopharma is developing cancer and infectious disease therpeutics.

History:

Ambrilia Biopharma was formed in 2006 through the merger of Procyon BioPharma and Cellpep Pharma

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
North America Europe

Research Focus:
Disease Therapeutics-Research Therapeutics-Development

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: